Danske Bank A S Sells 22,251 Shares of STERIS plc $STE

Danske Bank A S trimmed its holdings in STERIS plc (NYSE:STE) by 28.7% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 55,410 shares of the medical equipment provider’s stock after selling 22,251 shares during the quarter. Danske Bank A S’s holdings in STERIS were worth $14,048,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Vanguard Group Inc. raised its holdings in shares of STERIS by 0.6% in the fourth quarter. Vanguard Group Inc. now owns 12,286,535 shares of the medical equipment provider’s stock valued at $3,114,882,000 after buying an additional 73,014 shares during the last quarter. State Street Corp raised its holdings in shares of STERIS by 4.0% in the third quarter. State Street Corp now owns 4,354,839 shares of the medical equipment provider’s stock valued at $1,077,564,000 after buying an additional 166,736 shares during the last quarter. Orbis Allan Gray Ltd raised its holdings in shares of STERIS by 36.0% in the second quarter. Orbis Allan Gray Ltd now owns 2,100,099 shares of the medical equipment provider’s stock valued at $504,486,000 after buying an additional 556,088 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. raised its holdings in shares of STERIS by 16.4% in the third quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,567,238 shares of the medical equipment provider’s stock valued at $387,797,000 after buying an additional 221,199 shares during the last quarter. Finally, Invesco Ltd. raised its holdings in shares of STERIS by 4.9% in the third quarter. Invesco Ltd. now owns 1,280,142 shares of the medical equipment provider’s stock valued at $316,758,000 after buying an additional 59,443 shares during the last quarter. 94.69% of the stock is owned by institutional investors.

Analyst Ratings Changes

STE has been the subject of a number of research analyst reports. Wall Street Zen cut STERIS from a “strong-buy” rating to a “buy” rating in a report on Sunday, April 26th. Weiss Ratings cut STERIS from a “buy (b-)” rating to a “hold (c+)” rating in a report on Thursday, April 16th. Five research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company. According to MarketBeat, STERIS has a consensus rating of “Moderate Buy” and an average price target of $275.20.

Insiders Place Their Bets

In other STERIS news, Director Cynthia L. Feldmann sold 3,098 shares of the business’s stock in a transaction dated Thursday, March 5th. The stock was sold at an average price of $237.21, for a total transaction of $734,876.58. Following the completion of the sale, the director directly owned 705 shares of the company’s stock, valued at approximately $167,233.05. The trade was a 81.46% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Corporate insiders own 1.07% of the company’s stock.

STERIS Stock Performance

Shares of NYSE:STE opened at $214.78 on Monday. The stock has a market capitalization of $21.06 billion, a P/E ratio of 29.96 and a beta of 0.95. STERIS plc has a 1-year low of $209.98 and a 1-year high of $269.44. The company has a current ratio of 2.48, a quick ratio of 1.75 and a debt-to-equity ratio of 0.26. The business has a 50-day moving average price of $226.36 and a two-hundred day moving average price of $244.80.

STERIS (NYSE:STE) last announced its quarterly earnings data on Wednesday, February 4th. The medical equipment provider reported $2.53 earnings per share for the quarter, hitting the consensus estimate of $2.53. STERIS had a return on equity of 14.34% and a net margin of 12.15%.STERIS’s revenue for the quarter was up 9.2% on a year-over-year basis. During the same quarter in the previous year, the company posted $2.32 earnings per share. STERIS has set its FY 2026 guidance at 10.150-10.300 EPS. Equities analysts predict that STERIS plc will post 10.22 earnings per share for the current year.

About STERIS

STERIS Corporation (NYSE: STE) is a global provider of infection prevention, contamination control and procedural products and services for the healthcare, life sciences, pharmaceutical and medical device industries. The company develops, manufactures and supports a broad portfolio of equipment and consumables designed to reduce risk of infection, maintain sterile environments and support critical clinical and manufacturing procedures.

Its offerings include sterilization and decontamination systems, instrument washers and washers-disinfectors, endoscope reprocessing solutions, surgical equipment and procedural disposables, and contamination-control products for cleanrooms and laboratories.